Figure 2.
![Local distribution of newly acquired N-glycosylation sites (NANGS) in the entire cohort (FL stage I-IV, including relapsed FL). (A), in t(14;18)-positive [t(14;18) +] compared with t(14;18)-negative [t(14;18) -] FL of the entire cohort (B), and in t(14;18) + and t(14;18) - FL stages I to IV at relapse (R-FL I-IV), including FL of unknown stage (R-FL U) (C). FL I/II, early-stage FL; FL III/IV, advanced-stage FL.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/5/23/10.1182_bloodadvances.2021005081/2/advancesadv2021005081f2.png?Expires=1724944817&Signature=AvBv4hHsqCMjxEW4XMze9vyJRUdWRffEN8JotVGtCXXm1Z83lwkOoL4p2Cph7nVGu9mTcPDOIHhlGxj0ek4yP1SFAq1fu-B1O9TcdFN5-v4sDRB4-YfSBPTHXo4I75Agpv6z9epicGEmaedqm8K3lDOG1k1bVJOjE-HlFJ343aEWYTINsubdOTbCCOOgDDQl-~3zI81KUelJv7NhYDmE9lY0h0KZ5Li9de8LKhaovdMOffG~bKchPIhVEeCEfxsLmb-~3epGY1WBh69woraR0LYkUBZds06F2wnWwJM5OvrXvZqo6j~vpToGsVFh0BuCYY506-B5r8H1ZTO7D5h3OA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Local distribution of newly acquired N-glycosylation sites (NANGS) in the entire cohort (FL stage I-IV, including relapsed FL). (A), in t(14;18)-positive [t(14;18) +] compared with t(14;18)-negative [t(14;18) -] FL of the entire cohort (B), and in t(14;18) + and t(14;18) - FL stages I to IV at relapse (R-FL I-IV), including FL of unknown stage (R-FL U) (C). FL I/II, early-stage FL; FL III/IV, advanced-stage FL.